Trading Halt

Aug 16, 2026 at 7:53 PM EDT · Issued by Chimeric Therapeutics Limited via ASX

Filed with ASX · Aug 16, 2026 at 7:53 PM EDT

Market Announcement 17 August 2026 17 August 2026 Market Announcement 1/1 ASX Limited ASX Customer Service Centre 131 279 | asx.com.au #11126754v1 Chimeric Therapeutics Limited (ASX: CHM) – Trading Halt Trading in the securities of Chimeric Therapeutics Limited (‘...

View Attachment

6ix hasn’t read this filing yet.

Chimeric Therapeutics Limited on 6ix

Earlier from Chimeric Therapeutics

Application for quotation of securities - CHMAug 6
Quarterly Activities/Appendix 4C Cash Flow ReportJul 31
Chimeric receives $1.62M advance on FY26 R&D tax incentiveJul 29
Investor PresentationJul 27
CHM CDH17 Phase 1 clinical trial update - New DL 3 dataJul 15

Later from Chimeric Therapeutics

CHM ceases enrolment in Phase 1 trial and Company updateAug 18
Appendix 4E and Preliminary Final ReportAug 31
FY2026 Annual Report, creditor update and Board changesSep 30
Initial Director's Interest Notice - RMOct 5
Final Director's Interest Notice - BGOct 5

All Chimeric Therapeutics news releases

Follow Chimeric Therapeutics into a list and get an email when it puts out news.

Follow Chimeric Therapeutics